The largest prospective warfarin-treated cohort supports genetic forecasting

Genetic variants of cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) are known to influence warfarin dose, but the effect of other genes has not been fully elucidated. We genotyped 183 polymorphisms in 29 candidate genes in 1496 Swedish patients starting warfarin treatment, and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Wadelius, Mia, Chen, Leslie Y., Lindh, Jonatan D., Eriksson, Niclas, Ghori, Mohammed J. R., Bumpstead, Suzannah, Holm, Lennart, McGinnis, Ralph, Rane, Anders, Deloukas, Panos
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2009
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2630264/
https://ncbi.nlm.nih.gov/pubmed/18574025
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-04-149070
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados